Delivery Order SPE2DB20D1004-SPE2DB24FF6F1

Award Date 3/15/24
Potential Completion Date 3/18/24
Potential Value $1.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,779.16 for the supply of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products, specifically Fluticasone Prop 50 MCG Spray 16GM, to the Defense Logistics Agency (DLA). The $1,002.12 fixed-price delivery order contract has a performance period ending on March 13, 2023. There is no set-aside designation for this award. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,069.70, is a delivery order for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of December 1, 2023 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,773.49 for the supply of FLUTICASONE PROP HFA 110 MCG 12GM pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, and has an ultimate completion date of April 30, 2024. The contract is not designated as a set-aside and was awarded under a firm-fixed-price pricing type....
This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) has an award value of $1,658.24. The contract is for the delivery of fluticasone propionate HFA 110 mcg inhalers, with an ultimate completion date of March 3, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of Fluticasone Prop 50 MCG Spray 16GM medical products to the Defense Logistics Agency (DLA). The $1,374.62 firm fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, as a child contract under the parent company Cencora, Inc. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) under a $999,999,999 Indefinite Delivery Contract (IDC) to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific contract award is for the delivery of Fluticasone Prop 50 MCG Spray 16GM, with a ceiling value of $7,142.49 and a period of performance through March 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,797.94 firm fixed-price delivery order is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award, valued at $13,932.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
This federal contract award, valued at $9,196.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of February 6, 2024 and is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp, a major...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FF6F1
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $1,829.90 for the supply of Fluticasone Prop 50 MCG Spray 16GM. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation.

Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials, to support military healthcare programs globally. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 2/27/25, 9:57 AM